News & Articles

The company aims to meet the increased demand for approved media to maintain virus viability from sample collection to the lab

The Leo Foundation-funded study for first time identifies Sbi as the molecule that induces rapid release of Interleukin-33

The partnership aims to expand existing Monocyte Distribution Width (MDW) hematology-based biomarker to potentially aid in the rapid detection of MIS-C

The test uses a convolutional neural network to classify microscopy images of single intact particles of different viruses

In combination with other COVID-19 diagnostic tests, the Elecsys SARS-CoV-2 Antigen test can help in the management of patients for optimal care delivery

Availability of the new IgM blood test on the ARCHITECT and Alinity platforms is part of Abbott's effort to offer tests across the disease progression of COVID-19

Partnership combines Twist’s leadership in DNA synthesis and synthetic biology with Neogene’s expertise in personalized engineered T cell therapies

Summa Equity Fund II acquires a majority stake in Sengenics, a functional proteomics company with a unique technology for production of full-length, correctly folded and functional proteins

The DeNovix CellDrop™ Automated Cell Counter has been awarded the Gold Seal of Quality based on outstanding scientist reviews

Combination test for COVID-19, flu and other common respiratory illnesses helps health care professionals prepare for flu season

For their prize, Dr. Lieberman and her team have chosen to receive the upcoming low volume model, the microPro 25

The Phase II clinical trial, which will use cutting-edge CRISPR genetic engineering, has already begun enrolling patients

BotrytisAlert harnesses Mologic’s expert lateral flow technology to enable earlier disease intervention and prevent wide-spread crop failures

Access SARS-CoV-2 IgG assay shows excellent agreement with the Genscript Surrogate Virus Neutralization Test

Rentschler Biopharma to provide cGMP manufacturing services for mRNA-based vaccine candidate, developed by BioNTech and Pfizer against SARS-CoV-2

Samples from the lungs of patients show a runaway immune system reaction could be one mechanism behind severe COVID-19 cases